Category Archives: Patent Eligibility (101)

DC invalidation of “isolated” vitamin B3 compositions under 101 affirmed

Posted on February 15, 2023 by Patrick J. Halloran, Ph.D., J.D.

ChromaDex, Inc., Trustees of Dartmouth College v. Elysium Health, Inc. Docket No. 2022-1116 (https://cafc.uscourts.gov/opinions-orders/22-1116.OPINION.2-13-2023_2079642.pdf) PROST, CHEN, STOLL February 13, 2023 Brief Summary:   Invalidation of claims to isolated vitamin B3 (NR) compositions as unpatentable under section 101 affirmed. Summary:  ChromaDex … Continue reading →

Posted in Patent Eligibility (101), Patentability | Leave a comment

DC ineligibility findings for computer-related claims affirmed-in-part and reversed-in part as some showed improvement of “a problem unique to the Internet”

Posted on October 25, 2022 by Patrick J. Halloran, Ph.D., J.D.

Shalon Weisner and Shmuel Nemanov v. Google LLC Docket No. 2021-2228 (IPR2020-00040) (https://cafc.uscourts.gov/opinions-orders/21-2228.OPINION.10-13-2022_2017814.pdf) REYNA, HUGHES, STOLL October 13, 2022 Brief Summary:   DC decisions on patent ineligibility claims affirmed-in-part and reversed-in-part as two of the patents arguably “recite a specific … Continue reading →

Posted in Patent Eligibility (101), Section 101 (see also Patentability), Software | Leave a comment

Board decision finding ineligibility under section 101 affirmed (abstract idea, generic computer)

Posted on August 25, 2022 by Patrick J. Halloran, Ph.D., J.D.

In Re:  Jeffrey A. Killian Docket No. 2021-2113 (https://cafc.uscourts.gov/opinions-orders/21-2113.OPINION.8-23-2022_1994643.pdf) TARANTO, CLEVENGER, CHEN August 23, 2022 Brief Summary:   Board decision finding claims ineligible under section 101 affirmed. Summary:  Mr. Killian appealed USPTO Board decision affirming the examiner’s rejection of certain … Continue reading →

Posted in Patent Eligibility (101), Patentability, Software | Leave a comment

DC finding of Stanford’s organ rejection detection claims ineligible under section 101 affirmed

Posted on July 21, 2022 by Patrick J. Halloran, Ph.D., J.D.

CareDx, Inc. (Stanford Univ.) v. Natera, Inc. and Eurofins Viracor, Inc. Docket Nos. 2022-1027-8 (https://cafc.uscourts.gov/opinions-orders/22-1027.OPINION.7-18-2022_1979207.pdf) LOURIE, BRYSON, HUGHES July 18, 2022 Brief Summary:   Stanford’s claims to detecting organ rejection found ineligible under section 101 (e.g., “applying standard techniques in … Continue reading →

Posted in Method claims, Patent Eligibility (101), Patentability, Section 101 (see also Patentability) | Leave a comment

DC section 101 ineligibility decision reversed as “the particular arrangement of steps in claim 1 provides a technical improvement” over conventional methods

Posted on October 27, 2021 by Patrick J. Halloran, Ph.D., J.D.

CosmoKey Solutions Gmbh & Co. KG v. Duo Security LLC et al. Docket No. 2020-2043 (https://cafc.uscourts.gov/opinions-orders/20-2043.OPINION.10-4-2021_1843694.pdf) O’MALLEY, REYNA, STOLL October 4, 2021 Brief Summary:  DC decision finding CosmoKey’s claims unpatentable under section 101 reversed (e.g., “the particular arrangement of steps … Continue reading →

Posted in Patent Eligibility (101), Patentability, Section 101 (see also Patentability), Software | Leave a comment

Digital camera device claims affirmed as patent ineligible under section 101

Posted on June 14, 2021 by Patrick J. Halloran, Ph.D., J.D.

Yanbin Yu, et al. v. Apple Inc., Samsung Electronics Co., Ltd., et al. Docket No. 2020-1760 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1760.OPINION.6-11-2021_1789244.pdf) NEWMAN, PROST, TARANTO June 11, 2021 Brief Summary:  DC finding that claims to “improved digital camera” are patent ineligibile (101) affirmed (“whether a … Continue reading →

Posted in Patent Eligibility (101), Patentability | Leave a comment

Patent eligibility decision reversed (“claims do not at all describe how that result is achieved”) and claim construction affirmed based on specification

Posted on May 18, 2021 by Patrick J. Halloran, Ph.D., J.D.

First Stream Media Corp. (“Samba”) v. Alphonso Inc. et al. Docket No. 2019-1506, -2133 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-1506.OPINION.5-11-2021_1776030.pdf) DYK, REYNA, HUGHES May 11, 2021 Brief Summary:  DC eligibility (101) decision reversed (“claims do not at all describe how that result is achieved”); claim … Continue reading →

Posted in Claim Construction, Patent Eligibility (101), Software | Leave a comment

Rejection of Stanford’s genotyping claims affirmed as patent ineligible under section 101

Posted on March 26, 2021 by Patrick J. Halloran, Ph.D., J.D.

In re:  Board of Trustees of the Leland Stanford Junior University Docket No. 2020-1288 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1288.OPINION.3-25-2021_1753695.pdf) PROST, LOURIE, REYNA March 25, 2021 Brief Summary:  PTAB decision of ineligibility under section 101 of second Stanford patent application affirmed (“patent ineligible abstract ideas … Continue reading →

Posted in Inter Parties Review (IPR), IPR, Patent Eligibility (101), Patentability, Software | Leave a comment

Rejection of Stanford’s diagnostic claims affirmed as “mental steps… not integrated into a practical application”, not including a “specific method of treatment for specific patients using a specific compound at specific doses to achieve a specific outcome”

Posted on March 15, 2021 by Patrick J. Halloran, Ph.D., J.D.

In Re:  Board of Trustees of the Leland Stanford Junior University Docket No. 2020-1012 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1012.OPINION.3-11-2021_1746411.pdf) PROST, LOURIE, REYNA March 11, 2021 Brief Summary:  Board decision finding Stanford’s diagnostic claims ineligible (“mental steps… not integrated into a practical application”, no “specific … Continue reading →

Posted in Claim Construction, Patent Eligibility (101), Patentability, Section 101 (see also Patentability), Software | Leave a comment

DC claim construction and indefiniteness findings affirmed; ineligibility conclusions not reached by FC panel

Posted on February 15, 2021 by Patrick J. Halloran, Ph.D., J.D.

Synchronoss Techs., Inc. v. Dropbox, Inc., Funambol, Inc. Docket No. 2020-2196, -2199 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-2196.OPINION.2-12-2021_1732513.pdf) PROST, REYNA, TARANTO February 12, 2021 Brief Summary:  DC claim construction, invalidity for indefiniteness, and grant of SJ affirmed. Summary:  Synchronoss appealed DC claim constructions and grant … Continue reading →

Posted in Claim Construction, Indefiniteness, Means-plus-function, Patent Eligibility (101), Section 101 (see also Patentability), Software | Leave a comment